Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
6.15
+0.26 (4.41%)
At close: Mar 9, 2026, 4:00 PM EDT
5.85
-0.30 (-4.88%)
After-hours: Mar 9, 2026, 7:47 PM EDT
Atea Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 490 | 279 | 283 | 254 | 401 | 743 | |
| Market Cap Growth | 84.75% | -1.43% | 11.19% | -36.48% | -46.08% | -78.48% | |
| Enterprise Value | 189 | -49 | -198 | -338 | -261 | -96 | |
| Last Close Price | 6.15 | 3.57 | 3.35 | 3.05 | 4.81 | 8.94 | |
| PE Ratio | - | - | - | - | - | 6.13 | |
| PS Ratio | - | - | - | - | - | 2.11 | |
| PB Ratio | 1.74 | 1.01 | 0.65 | 0.46 | 0.63 | 1.05 | |
| P/TBV Ratio | 1.78 | 1.01 | 0.65 | 0.46 | 0.63 | 1.05 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.00 | |
| Net Debt / Equity Ratio | -1.09 | -1.09 | -1.03 | -1.04 | -1.00 | -1.08 | |
| Net Debt / EBITDA Ratio | 1.68 | 1.68 | 3.44 | 4.79 | 5.81 | -5.52 | |
| Net Debt / FCF Ratio | 2.28 | 2.28 | 3.34 | 6.74 | 5.24 | 8.78 | |
| Asset Turnover | - | - | - | - | - | 0.43 | |
| Quick Ratio | 7.59 | 7.59 | 24.44 | 18.04 | 35.00 | 13.44 | |
| Current Ratio | 7.82 | 7.82 | 24.85 | 18.24 | 35.77 | 13.58 | |
| Return on Equity (ROE) | -44.34% | -44.34% | -33.88% | -22.74% | -17.16% | 19.27% | |
| Return on Assets (ROA) | -28.75% | -28.75% | -15.60% | -11.94% | -9.65% | 10.57% | |
| Return on Capital Employed (ROCE) | -65.10% | -65.10% | -29.60% | -21.40% | -17.10% | 19.30% | |
| Earnings Yield | -32.32% | -56.77% | -59.51% | -53.42% | -28.93% | 16.31% | |
| FCF Yield | -26.95% | -47.34% | -47.89% | -33.56% | -30.68% | -11.71% | |
| Buyback Yield / Dilution | 3.29% | 3.29% | -1.05% | -0.17% | 5.67% | -308.70% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.